Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 10.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.00
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 121.72m
  • Volume: 112,380
  • Market Cap: £12.17m

Abingdon Health progresses at-home STD test programme

By Josh White

Date: Monday 25 Mar 2024

LONDON (ShareCast) - (Sharecast News) - Abingdon Health updated the market on the development of self-tests for sexually transmitted diseases (STDs) on Monday, announcing the completion of the 'design freeze' stage for four key tests in collaboration with Devyn.
The AIM-traded firm said the tests, covering HIV, hepatitis B, hepatitis C and syphilis, were developed under a CDMO contract with Devyn's subsidiary 'Find Out From Home'.

It said the development was part of a broader strategic partnership between Abingdon Health and Find Out, formalised through a service for equity agreement.

Under the agreement, Abingdon would continue to offer regulatory and technical transfer services, and also take a significant minority equity stake in Find Out.

As the exclusive manufacturer and regulatory partner for the products, Abingdon Health said it would lead distribution in the UK and Europe.

The initiative could tap into a growing demand for STD testing, with the global market expected to reach $145bn by 2035, driven by increasing STD cases among young adults and a lack of awareness about safe sex practices.

Abingdon said its chief executive officer Chris Yates would join the board of Find Out, further cementing the strategic alignment between the two entities.

"We are delighted to announce the strategic partnership with Find Out From Home," said chief executive officer Chris Yates.

"We have been working with the team at Find Out for the past year and are pleased that the initial set of four STD lateral flow tests have now reached design freeze."

Yates said the company was looking forward to deepening its partnership with Find Out, and ultimately launching the rapid STD tests into the European market.

"We believe there is a significant unmet need for accurate, user-friendly STD lateral flow tests and this partnership underlines our approach in supporting customers on bringing innovative lateral flow tests from "idea to commercial success."

At 1500 GMT, shares in Abingdon Health were up 8.11% at 10p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 10.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.00
52 Week Low 6.75
Volume 112,380
Shares Issued 121.72m
Market Cap £12.17m

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.57% below the market average42.57% below the market average42.57% below the market average42.57% below the market average42.57% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average
Price Trend
21.70% above the market average21.70% above the market average21.70% above the market average21.70% above the market average21.70% above the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Income Not Available
Growth
3.26% above the market average3.26% above the market average3.26% above the market average3.26% above the market average3.26% above the market average
5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average

ABDX Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
15:42 1,000 @ 10.04p
15:04 872 @ 10.38p
14:46 10,407 @ 9.70p
14:14 8,247 @ 10.04p
14:07 405 @ 10.50p

ABDX Key Personnel

CEO Chris Henry Francis Yates

Top of Page